Medications
Pfizer buying two meningitis vaccines from Glaxo for $130M
Pfizer will buy two meningitis vaccines from GlaxoSmithKline in a deal that the U.S. drugmaker valued at about $130 million.
Jun 22, 2015
0
3
Page 30 - News tagged with pfizer
Medications
Pfizer stops China vaccine sales as import license expires
Pfizer has stopped selling its Prevnar 7 pneumonia vaccine in China after its import license expired, but the U.S. drugmaker still intends to launch the world's most widely used vaccine, Prevnar 13, in that market.
Apr 2, 2015
0
2
Medications
Prevnar, Pfizer's pneumonia vaccine, okayed for adults in EU
Pfizer's blockbuster vaccine against pneumonia and other bacterial infections has won another approval, for use in European Union residents aged 18 and older.
Mar 3, 2015
0
3
Oncology & Cancer
New opportunity to treat drug-resistant leukemia discovered
A study led by researchers at the Institute for Molecular Medicine Finland FIMM and Faculty of Medicine, University of Helsinki and the Helsinki University Central Hospital Comprehensive Cancer Center, in close collaboration ...
Feb 9, 2015
1
46
Other
Pfizer net down on lower sales, higher research, legal costs
Pfizer Inc.'s fourth-quarter profit fell by half as worsening generic competition and unfavorable currency rates reduced sales, and higher research and legal costs also reduced the bottom line.
Jan 27, 2015
0
2
Medications
Analysts: Pfizer's new type of cancer drug may get OK early (Update)
The first in a new class of cancer medicines, Pfizer's Ibrance, appears poised for approval to treat advanced breast cancer within a few months and could quickly become a blockbuster, some analysts believe.
Jan 8, 2015
0
10
Medications
Pfizer closes $635M vaccines purchase from Baxter
Pfizer has completed its $635 million purchase from Baxter International Inc. of two vaccines and part of the factory in Orth, Austria, where they're made.
Dec 1, 2014
0
0
Medications
US, German drugmakers team up on cancer medicines
Pfizer said Monday that it will partner with German drug and chemical maker Merck in developing potential cancer drugs in a hot new medication class that harnesses the body's immune system to fight cancer.
Nov 17, 2014
0
0
Medications
FDA approves vaccine to block meningitis strain (Update)
Federal health regulators have approved the first vaccine to block a strain of bacteria that has caused sometimes deadly outbreaks of meningitis in college dormitories.
Oct 29, 2014
0
0
Medications
FDA weighs removing bolded warning from Chantix
(AP)—The Food and Drug Administration will ask a panel of experts later this week whether a bold-letter warning on the anti-smoking drug Chantix should be removed based on company-supported evidence that the drug does not ...
Oct 14, 2014
0
0
